Founder & Editor-in-Chief CriticalCareDVM.com Omaha, Nebraska, United States
Disclosure(s):
Christopher G. Byers, DVM, DACVECC, DACVIM (SAIM), CVJ: Blue Buffalo: Fetch Coastal 2025 (Terminated); Boehringer Ingelheim: Advisor (Ongoing), Multiple conferences (Ongoing); Ceva Animal Heatlh: Multiple CE events (Ongoing); Dechra Veterinary Products: Internal Medicine & Anesthesia/Fluid Therapy Portfolios (Ongoing), Multiple conferences (Ongoing); Royal Canin: Multiple CE events (Ongoing)
Vomiting is among the most common clinical signs encountered in small animal practice, yet choosing the most appropriate anti-emetic therapy can be challenging. This session will use real-world case examples to highlight the practical application of anti-emetic strategies in both dogs and cats. Attendees will learn how to select and administer therapies across primary care, urgent care, and emergency settings, with a focus on optimizing patient comfort and clinical outcomes. Discussion will emphasize the role of maropitant and other anti-emetic options, offering evidence-based, case-driven insights that can be immediately applied in practice.
Learning Objectives:
Identify common causes of vomiting in dogs and cats across primary care, urgent care, and emergency settings.
Compare the mechanisms of action, indications, and limitations of maropitant and other anti-emetic therapies.
Apply evidence-based criteria to select appropriate anti-emetic treatment strategies tailored to individual patient needs.
Interpret real-world case examples to guide clinical decision-making and improve patient outcomes.
.png)
